The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 2,201–2,400 of 3,517
Pozzi, L., Invernizzi, R. W., Garavaglia, C., & SAMANIN, R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731051.x · Cited by 87
Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression
Swaab, D. F., Fliers, E., Hoogendijk, W. J. G., Veltman, D. J., & Zhou, J. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)26025-1 · Cited by 87
Millan, M. J., Lejeune, F., Gobert, A., et al. (2000) · PubMed · Cited by 87
Self-citationKhisti, R. T., & Chopde, C. T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02373-8 · Cited by 87
Bouali, S., Evrard, A., Chastanet, M., Lesch, K., Hamon, M., & Adrien, J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02960.x · Cited by 87
Newman‐Tancredi, A., Conte, C., Chaput, C., Verrièle, L., & Millan, M. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00022-1 · Cited by 87
Self-citationAlternative splicing in the nervous system: an emerging source of diversity and regulation
Lee, C. J., & Irizarry, K. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00375-5 · Cited by 87
Adaptive evolution after gene duplication
Hughes, A. L. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02755-5 · Cited by 87
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice
Nielsen, D. M., Carey, G. J., & Gold, L. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.091 · Cited by 87
Cussac, D., Newman‐Tancredi, A., Quentric, Y., Carpentier, N., Poissonnet, G., Parmentier, J., Goldstein, S., & Millan, M. J. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-001-0505-y · Cited by 87
Self-citationThe GABAB receptor antagonist CGP36742 improves learned helplessness in rats
Nakagawa, Y., Sasaki, A., & Takashima, T. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00567-1 · Cited by 87
Ito, K., Yoshida, K., Sato, K., Takahashi, H., Kamata, M., Higuchi, H., Shimizu, T., Itoh, K., Inoue, K., Tezuka, T., et al. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00141-5 · Cited by 87
Cellular expression of mRNAs encoding monoamine oxidases A and B in the rat central nervous system
Luque, J. M., Kwan, S., Abell, C. W., Prada, M. D., & Richards, J. G. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903630410 · Cited by 87
Lapins, M., Prūsis, P., Lundstedt, T., & Wikberg, J. E. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.6.1465 · Cited by 87
Association of Depressive Symptoms During Abstinence With the Subjective High Produced by Cocaine
Uslaner, J. M., Kalechstein, A. D., Richter, T., Ling, W. W., & Newton, T. F. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1444 · Cited by 87
“Broad spectrum” antidepressants: Is more better for the treatment of depression?
Skolnick, P., Popik, P., Janowsky, A. J., Beer, B., & LIPPA, A. S. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.06.007 · Cited by 87
Cognitive deficits are associated with functional impairment in severely depressed patients
Vaughn McCall, W., & Dunn, A. G. (2003) · Psychiatry Research · doi:10.1016/j.psychres.2003.09.003 · Cited by 86
Geriatric Depression Treatment in Nonresponders to Selective Serotonin Reuptake Inhibitors
Whyte, E. M., Basinski, J., Farhi, P., Dew, M. A., Begley, A., Mulsant, B. H., & Reynolds, C. F. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1208 · Cited by 86
Wang, H., Hsu, C., Huang, P., Kuo, Y.-L., Li, A. H.-L., Yeh, T., Tso, A., & Chen, Y. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02921.x · Cited by 86
Vázquez‐Prado, J. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00151-1 · Cited by 86
Mining and Visualizing Large Anticancer Drug Discovery Databases
Shi, L. M., Fan, Y., Lee, J. K., Waltham, M. C., Andrews, D. T., Scherf, U., Paull, K. D., & Weinstein, J. N. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990087b · Cited by 86
Clinical experience with dual action antidepressants in different chronic pain syndromes
Briley, M. (2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.621 · Cited by 86
ECT of Major Depressed Patients in Relation to Biological and Clinical Variables: A Brief Overview
Wahlund, B., & von Rosen, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300135 · Cited by 86
Distribution of the GABAB receptor subunit gb2 in rat CNS
Clark, J. A., Mezey, É., Lam, A. S., & Bonner, T. I. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01958-2 · Cited by 86
Heese, K., Otten, U., Mathivet, P., Raiteri, M., Marescaux, C., & Bernasconi, R. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00166-5 · Cited by 86
NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.
Farlow, M. R. (2004) · PubMed · Cited by 86
Glia and volume transmission during physiological and pathological states
Sykov�, E. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0120-4 · Cited by 85
Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain
Maj, J., Dziedzicka‐Wasylewska, M., Rogoż, R., & Rogóż, Z. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00297-0 · Cited by 85
Developing novel treatments for mood disorders: accelerating discovery
Tamminga, C. A., Nemeroff, C. B., Blakely, R., Brady, L. S., Carter, C. S., Davis, K. L., Dingledine, R. J., Gorman, J. M., Grigoriadis, D. E., Henderson, D. C., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01470-1 · Cited by 85
Combined Treatment With Methylphenidate and Citalopram for Accelerated Response in the Elderly
Lavretsky, H., Kim, M.-D., Kumar, A., & Reynolds, C. F. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1202 · Cited by 85
Hill, M. N., Brotto, L. A., Lee, T. T.-Y., & Gorzalka, B. B. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00149-0 · Cited by 85
The effect of tianeptine and sertraline in three animal models of depression
KELLY, J., & Leonard, B. E. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90160-0 · Cited by 85
Ferguson, S. M., Brodkin, J. D., Kenneth Lloyd, G., & Menzaghi, F. (2000) · Psychopharmacology · doi:10.1007/s002130000531 · Cited by 85
Hildebrand, M. E., McRory, J. E., Snutch, T. P., & Stea, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058792 · Cited by 85
The discovery of susceptibility genes for mental disorders
Cloninger, C. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222532599 · Cited by 85
Sexual dysfunction associated with antidepressant drugs
Baldwin, D. S. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.5.457 · Cited by 84
Hicks, J. A., Argyropoulos, S. V., Rich, A. S., Nash, J., Bell, C. J., Edwards, C., Nutt, D. J., & Wilson, S. J. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.6.528 · Cited by 84
Knobelman, D. A., Hen, R., & Lucki, I. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29477-5 · Cited by 84
The pharmacogenomics of selective serotonin reuptake inhibitors
Serretti, A., & Artioli, P. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500250 · Cited by 84
Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice
El-Ghundi, M., O’Dowd, B. F., Erclik, M. S., & George, S. R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02496.x · Cited by 84
Kugaya, A., Sanacora, G., Staley, J. K., Malison, R. T., Bozkurt, A., Khan, S. A., Anand, A., van Dyck, C. H., Baldwin, R. M., Seibyl, J. P., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.001 · Cited by 84
Allosteric modulation of G protein-coupled receptors: perspectives and recent developments
Soudijn, W., van Wijngaarden, I., & IJzerman, A. P. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03220-9 · Cited by 84
Maskell, P., Spéder, P., Newberry, N. R., & Bermúdez, I. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705559 · Cited by 84
Harrist, A. V., Beech, R. D., King, S. L., Zanardi, A., Cleary, M. A., Caldarone, B. J., Eisch, A. J., Zoli, M., & Picciotto, M. R. (2004) · Synapse · doi:10.1002/syn.20081 · Cited by 84
Inhibition of Subjective and Physiological Sexual Arousal in Women by Clonidine
Meston, C. M., Gorzalka, B. B., & Wright, J. M. (1997) · Psychosomatic Medicine · doi:10.1097/00006842-199707000-00010 · Cited by 84
Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead
Nebert, D. W., & Vesell, E. S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.031 · Cited by 84
Meyerson, L. R., Ieni, J. R., & Wennogle, L. P. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb04129.x · Cited by 84
Sleep and fatigue in Parkinson's disease
Friedman, J. H., & Chou, K. L. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.11.006 · Cited by 84
Emotion and cortical-subcortical function: conceptual developments
Bennett, M. H., & Hacker, P. M. S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.11.002 · Cited by 84
5-HT2C receptor activation by m-chlorophenylpiperazine detected in humans with fMRI
Anderson, I. M., Clark, L., Elliott, R., Kulkarni, B., Williams, S. R., & Deakin, J. F. W. (2002) · Neuroreport · doi:10.1097/00001756-200208270-00012 · Cited by 84
Abi‐Dargham, A., Kegeles, L. S., Martínez, D., Innis, R. B., & Laruelle, M. A. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.007 · Cited by 84
Constant, E. L., Adam, S., Gillain, B., Seron, X., Bruyer, R., & Seghers, A. (2005) · Depression and Anxiety · doi:10.1002/da.20060 · Cited by 83
Anthony, J. P., Sexton, T. J., & Neumaier, J. F. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000701)61:1<82::aid-jnr10>3.0.co;2-e · Cited by 83
Residual Symptoms in Depression: Can Treatment Be Symptom-Specific?
Menza, M. A., Marín, H., & Opper, R. S. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0504 · Cited by 83
Does Mirtazapine Have a More Rapid Onset Than SSRIs?
Quitkin, F. M., Taylor, B. P., & Kremer, C. M. E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0509 · Cited by 83
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer’s disease
Sjögren, M. J. C., Minthon, L., Passant, U., Blennow, K., & Wallin, A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00086-4 · Cited by 83
Dopamine receptor agonists in the therapy of Parkinson?s disease
Foley, P., Gerlach, M., Double, K. L., & Riederer, P. F. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0059-x · Cited by 83
Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats
Padovan, C. M., & Guimarães, F. S. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.09.015 · Cited by 83
Picconi, B., Centonze, D., Rossi, S., Bernardi, G., & Calabresi, P. (2004) · Brain · doi:10.1093/brain/awh190 · Cited by 83
DeBattista, C., Solvason, H. B., Poirier, J., Kendrick, E., & Schatzberg, A. F. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00005 · Cited by 83
Sanger, G. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705742 · Cited by 83
5‐HT1B Receptor‐Mediated Regulation of Serotonin Clearance in Rat Hippocampus In Vivo
Daws, L. C., Gould, G. G., Teicher, S., Gerhardt, G. A., & Frazer, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752113.x · Cited by 83
Corticosterone influences forced swim-induced immobility
Báez, M., & Volosin, M. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90093-0 · Cited by 83
Substitution of an SSRI With Bupropion Sustained Release Following SSRI-Induced Sexual Dysfunction
Clayton, A. H., McGarvey, E. L., Abouesh, A., & Pinkerton, R. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0309 · Cited by 83
Nurnberg, H. G., Gelenberg, A. J., Hargreave, T. B., Harrison, W. M., Siegel, R. L., & Smith, M. D. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1926 · Cited by 83
Neuropeptides and Electroconvulsive Treatment
Math�, A. A. (1999) · Journal of Ect · doi:10.1097/00124509-199903000-00006 · Cited by 83
Fk, G., Wirz‐Justice, A., & Ta, W. (1982) · PubMed · Cited by 83
Behavioral studies of serotonin receptor agonists as antidepressant drugs.
Burrows, G. D., Norman, T. R., & Judd, F. K. (1991) · PubMed · Cited by 83
Wirz‐Justice, A., Terman, M., Oren, D. A., Goodwin, F. K., Kripke, D. F., Whybrow, P. C., Wisner, K. L., Wu, J. C., Lam, R. W. M., Berger, T., et al. (2004) · Science · doi:10.1126/science.303.5657.467c · Cited by 83
Fawzi, A. B., Macdonald, D., Benbow, L. L., Smith-Torhan, A., Zhang, H., Weig, B. C., Ho, G., Tulshian, D., Linder, M. E., & Graziano, M. P. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12353-x · Cited by 82
Cell and Molecular Cell Biology of Melanin-Concentrating Hormone
Griffond, B., & Baker, B. I. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)13016-6 · Cited by 82
The Mechanism of Action of Vagus Nerve Stimulation for Refractory Epilepsy: The Current Status
Vonck, K. E. J., Laere, K. V., Dedeurwaerdere, S., Caemaert, J., Reuck, J. D., & Boon, P. (2001) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200109000-00002 · Cited by 82
Jarrett, D. B. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810140013002 · Cited by 82
Antidepressant drug treatment induces Arc gene expression in the rat brain
Pei, Q., Zetterström, T., Sprakes, M., Tordera, R. M., & Sharp, T. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00504-9 · Cited by 82
A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo in Outpatients with Major Depression
D, M. F. M., Amsterdam, J. D., Deltito, J. A., Salzman, C., Schwaller, M., & Dünner, D. L. (1998) · Annals of Clinical Psychiatry · doi:10.1023/a:1022337927842 · Cited by 82
Smith, J. C. E., & Whitton, P. S. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01378-1 · Cited by 82
Landén, M., Högberg, P., & Thase, M. E. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0114 · Cited by 82
Volk, C., Gorboulev, V., Budiman, T., Nagel, G., & Koepsell, H. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1037 · Cited by 82
Motohashi, N., Ikawa, K., & Kariya, T. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90687-0 · Cited by 82
Sebban, C., Zhang, X. Q., Tesolin, B., Millan, M. J., & Spedding, M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702894 · Cited by 82
Self-citationPindolol augmentation of antidepressant therapy
McAskill, R., Mir, S., & Taylor, D. M. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.3.203 · Cited by 81
Peñalva, R. G., Lancel, M., Flachskamm, C., Reul, J. M. H. M., Holsboer, F., & Linthorst, A. C. E. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02612.x · Cited by 81
Subthreshold depression is linked to the functional polymorphism of the 5HT transporter gene
Gonda, X., Juhász, G., Lászik, A., Rihmer, Z., & Bagdy, G. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.05.007 · Cited by 81
Kokare, D. M., Dandekar, M. P., Chopde, C. T., & Subhedar, N. K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.038 · Cited by 81
Estradiol Induces Formation of Dendritic Spines in Hippocampal Neurons: Functional Correlates
Segal, M., & Murphy, D. (2001) · Hormones and Behavior · doi:10.1006/hbeh.2001.1688 · Cited by 81
Mathé, A. A., Jimenez, P. A., Theodorsson, E., & Stenfors, C. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00023-2 · Cited by 81
Xu, H., Luo, C., Richardson, J. S., & Li, X.-M. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500265 · Cited by 81
Substance P (Neurokinin 1) Receptor Antagonists Enhance Dorsal Raphe Neuronal Activity
Conley, R. K., Cumberbatch, M. J., Mason, G. S., Williamson, D. J., Harrison, T., Locker, K. L., Swain, C. J., Maubach, K. A., O’Donnell, R., Rigby, M., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07730.2002 · Cited by 81
Discriminative-stimulus effects of modafinil in cocaine-trained humans
Rush, C. R., Kelly, T. H., Hays, L. R., & Wooten, A. F. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00082-0 · Cited by 81
DeBock, F., Kurz, J., Azad, S. C., Parsons, C. G., Hapfelmeier, G., Zieglgänsberger, W., & Rammes, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02544.x · Cited by 81
Use of melatonin for sleep and circadian rhythm disorders
Sack, R. L., Lewy, A. J., & Hughes, R. J. (1998) · Annals of Medicine · doi:10.3109/07853899808999393 · Cited by 80
Generalised Anxiety Disorder: Treatment Options
Sramek, J. J., Zarotsky, V., & Cutler, N. R. (2002) · Drugs · doi:10.2165/00003495-200262110-00005 · Cited by 80
Sustained antidepressant effect of PEA replacement
SABELLI, H. C., Fink, P., FAWCETT, J. A., & Tom, C. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.2.168 · Cited by 80
Tramadol hydrochloride: an overview of current use.
Bamigbade, T. A., & Langford, R. M. (1998) · PubMed · Cited by 80
α2A and α2C‐adrenoceptor regulation in the brain: α2A changes persist after chronic stress
Flügge, G., Kampen, M. V., Meyer, H. H. D., & Fuchs, E. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02510.x · Cited by 80
Nierenberg, A. A., Petersen, T., & Alpert, J. E. (2003) · PubMed · Cited by 80
Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
Smith, W. T., Londborg, P. D., Glaudin, V., & Painter, J. R. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00352-4 · Cited by 80
The trace amines and their acidic metabolites in depression — an overview
Davis, B. A., & Boulton, A. A. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90022-1 · Cited by 80
Basheer, R., Magner, M., McCarley, R. W., & Shiromani, P. J. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00088-6 · Cited by 80
Antidepressants Reduce Whole-Body Norepinephrine Turnover While Enhancing 6-Hydroxymelatonin Output
Golden, R. N., Markey, S. P., Risby, E. D., Rudorfer, M. V., Cowdry, R. W., & Potter, W. Z. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260060008 · Cited by 80
SIRINATHSINGHJI, D. J. S. (1987) · Brain Research · doi:10.1016/0006-8993(87)91236-4 · Cited by 80
Organization of Neuropeptide Y Neurons in the Mammalian Central Nervous System
Hendry, S. H. C. (1993) · Humana Press eBooks · doi:10.1007/978-1-59259-465-8_3 · Cited by 80
Chapter 29. Principles for multivalent ligand design
Kiessling, L. L., Strong, L. E., & Gestwicki, J. E. (2000) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(00)35030-8 · Cited by 79
The Royal College of General Practitioners’ Oral Contraception Study: Some Recent Observations
Kay, C. R. (1984) · Clinics in Obstetrics and Gynaecology · doi:10.1016/s0306-3356(21)00626-9 · Cited by 79
Mashiko, S., Ishihara, A., Gomori, A., Moriya, R., Ito, M., Iwaasa, H., Matsuda, M., Feng, Y., Shen, Z., Marsh, D. J., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1150 · Cited by 79
Montorsi, F., Ferini‐Strambi, L., Guazzoni, G. F., Galli, L., Barbieri, L., Rigatti, P., Pizzini, G., & Miani, A. (1994) · Urology · doi:10.1016/s0090-4295(94)80216-5 · Cited by 79
Urwyler, S., Gjoni, T., KOLJATIC, J., & Dupuis, D. S. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.10.013 · Cited by 79
Bachmann, C. G., Linthorst, A. C. E., Holsboer, F., & Reul, J. M. H. M. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300158 · Cited by 79
Difference in serotonergic and noradrenergic regulation of human social behaviours
Tse, W. S., & Bond, A. J. (2001) · Psychopharmacology · doi:10.1007/s00213-001-0926-9 · Cited by 79
Blurton-Jones, M. M., Kuan, P. N., & Tuszynski, M. H. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10989 · Cited by 79
Facilitation of Lordosis by Injection of Substance P into the Midbrain Central Gray
Dornan, W. A., Malsbury, C. W., & Penney, R. B. (2008) · Neuroendocrinology · doi:10.1159/000124781 · Cited by 79
Addition of the α2-Antagonist Yohimbine to Fluoxetine: Effects on Rate of Antidepressant Response
Sanacora, G., Berman, R., Cappiello, A., Oren, D. A., Kugaya, A., Liu, N., Gueorguieva, R. V., Fasula, D., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300418 · Cited by 79
Interaction of zinc with antidepressants in the forced swimming test in mice.
Szewczyk, B., Brański, P., Wierońska, J. M., Pałucha-Poniewiera, A., Pilc, A., & Nowak, G. (2002) · PubMed · Cited by 79
Effect of sildenafil on anxiety in the plus-maze test in mice.
Kurt, M., Bilge, S. S., Aksöz, E., Kukula, O., Celik, S., & Kesim, Y. (2004) · PubMed · Cited by 78
Mortensen, O. V., Kristensen, A. S., & Wiborg, O. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00587.x · Cited by 78
Dopamine Reuptake by Norepinephrine Neurons: Exception or Rule?
Carboni, E., & Silvagni, A. (2004) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v16.i12.130 · Cited by 78
Genotypes, Phenotypes, and the Brain
Tsuang, M. T. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.3.299 · Cited by 78
Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry
Daws, L. C., Montañez, S., Owens, W. A., Gould, G. G., Frazer, A., Toney, G. M., & Gerhardt, G. A. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.09.011 · Cited by 78
Dopamine transporter‐dependent and ‐independent actions of trace amine β‐phenylethylamine
Sotnikova, T. D., Budygin, E. A., Jones, S. R., Dykstra, L., Caron, M. G., & Gainetdinov, R. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02721.x · Cited by 78
Long-Term Antidepressant Efficacy and Safety of Olanzapine/Fluoxetine Combination
Corya, S. A., Andersen, S. W., Detke, H. C., Kelly, L. S., Campen, L. E. V., Sanger, T. M., Williamson, D. J., & Dubé, S. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1111 · Cited by 78
Papoucheva, E., Dumuis, A., Sebben, M., Richter, D. W., & Ponimaskin, E. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308177200 · Cited by 78
Koerselman, F., Laman, D. M., van Duijn, H., van Duijn, M. A. J., & Willems, M. A. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1005 · Cited by 78
Some proposals regarding the organization of the central nervous system control of penile erection
McKenna, K. E. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00021-x · Cited by 78
Antisense Inhibition of 5-Hydroxytryptamine2aReceptor Induces an Antidepressant-Like Effect in Mice
Sibille, E. L., Sarnyai, Z., Benjamin, D., Gál, J., Baker, H., & Tóth, M. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1056 · Cited by 78
Revicki, D. A., Siddique, J., Frank, L. B., Chung, J. Y., Green, B. L., KRUPNICK, J. L., Prasad, M., & Miranda, J. M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.868 · Cited by 78
Phenylethylamine modulation of affect: therapeutic and diagnostic implications
SABELLI, H. C., & Javaid, J. I. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.1.6 · Cited by 78
(1999) · PubMed · Cited by 77
Selective serotonin reuptake inhibitor discontinuation syndrome: A review
Tamam, L., & Özpoyraz, N. (2002) · Advances in Therapy · doi:10.1007/bf02850015 · Cited by 77
Cyproheptadine Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors
Aizenberg, D., Zemishlany, Z., & Weizman, A. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199508000-00003 · Cited by 77
Benzodiazepines for depression? A review of the literature
Birkenhäger, T. K., Moleman, P., & Nolen, W. A. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199510030-00008 · Cited by 77
Curran, H. V., Sakulsriprong, M., & LADER, M. H. (1988) · Psychopharmacology · doi:10.1007/bf00172967 · Cited by 77
Sobreviela, T., Pagcatipunan, M., Kroin, J. S., & Mufson, E. J. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961118)375:3<417::aid-cne6>3.0.co;2-5 · Cited by 77
Gobbi, G., & Blier, P. (2005) · Peptides · doi:10.1016/j.peptides.2005.03.032 · Cited by 77
The dopamine D4 receptors and mechanisms of antipsychotic atypicality
Wong, A. H. C., & Tol, H. H. M. V. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.005 · Cited by 77
GABAB receptor alterations as indicators of physiological and pharmacological function
Enna, S. J., & Bowery, N. G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.037 · Cited by 77
Kitami, T., & Nadeau, J. H. (2002) · Nature Genetics · doi:10.1038/ng945 · Cited by 77
Weinstock, M., Gorodetsky, E. K., Poltyrev, T., Gross, A., Sagi, Y., & Youdim, M. B. H. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00053-8 · Cited by 77
Shytle, R. D., Silver, A. A., Sheehan, K. H., Sheehan, D. V., & Sanberg, P. R. (2002) · Depression and Anxiety · doi:10.1002/da.10035 · Cited by 77
Neuropeptides in Hypothalamic Neuronal Disorders
Swaab, D. F. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)40003-5 · Cited by 77
Manji, H. K., Hsiao, J. K., Risby, E. D., Oliver, J., Rudorfer, M. V., & Potter, W. Z. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810300017003 · Cited by 77
Rabiner, E. A., Bhagwagar, Z., Gunn, R. N., Sargent, P. A., Bench, C. J., Cowen, P. J., & Grasby, P. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2080 · Cited by 77
Oral drug therapy for erectile dysfunction
Padma-Nathan, H., & Giuliano, F. (2001) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70141-5 · Cited by 77
Schmitt, J. A. J., Ramaekers, J. G., Kruizinga, M. J., van Boxtel, M. P. J., Vuurman, E. F. P. M., & Riedel, W. J. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600303 · Cited by 76
Zemlan, F. P., Mulchahey, J. J., Scharf, M. B., Mayleben, D. W., Rosenberg, R. P., & Lankford, A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0316 · Cited by 76
Besson, A., Haddjeri, N., Blier, P., & de Montigny, C. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00069-9 · Cited by 76
Behavioral Effects of d-Opioid Receptor Agonists: Potential Antidepressants?
Broom, D. C., Jutkiewicz, E. M., Rice, K. C., Traynor, J. R., & Woods, J. H. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.90.1 · Cited by 76
Prevalence and background factorsof depression in first admittedschizophrenic patients
Bottlender, R., Strauß, A., & Möller, H. ‐. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.90063.x · Cited by 76
Lack of reward and locomotor stimulation induced by heroin in μ-opioid receptor-deficient mice
Contarino, A., Picetti, R., Matthes, H. W. D., Koob, G. F., Kieffer, B. L., & Gold, L. H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01812-5 · Cited by 76
Selective Estrogen Receptor Modulators: Tissue Actions and Potential for CNS Protection
Littleton‐Kearney, M. T., Ostrowski, N. L., Cox, D. A., Rossberg, M. I., & Hurn, P. D. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00230.x · Cited by 76
Lieb, K. P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00369-x · Cited by 76
Skalisz, L. L. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00333-5 · Cited by 76
Blier, P., Gobbi, G., Haddjeri, N., Santarelli, L., Mathew, G., & Hen, R. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0423 · Cited by 76
Riedel, W. J., Eikmans, K., Heldens, A., & Schmitt, J. A. J. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048887 · Cited by 76
Excitatory Mechanisms in the Suprachiasmatic Nucleus: The Role of AMPA/KA Glutamate Receptors
Michel, S. H., Itri, J. N., & Colwell, C. S. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.2.817 · Cited by 75
Brink, C. B., Harvey, B. H., Bodenstein, J., Venter, D. P., & Oliver, D. W. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02046.x · Cited by 75
Bontempi, B., Whelan, K. T., Risbrough, V. B., Lloyd, G. K., & Menzaghi, F. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300150 · Cited by 75
Hahn, B., Shoaib, M., & Stolerman, I. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1438-6 · Cited by 75
Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders
George, M. S., Rush, A. J., Sackeïm, H. A., & Marangell, L. B. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003250 · Cited by 75
Anxiolytic-Like Effects of 7-Nitroindazole in the Rat Plus-Maze Test
Yildiz, F., Ulak, G., Erden, F., & Gacar, N. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00133-1 · Cited by 75
DeBattista, C., Solvason, H. B., Poirier, J., Kendrick, E., & Loraas, E. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0706 · Cited by 75
Abell�n, M. T., Jolas, T., Aghajanian, G. K., & Artigas, F. (2000) · Synapse · Cited by 75
Erhardt, A., Sillaber, I., Welt, T., Müller, M. B., Singewald, N., & Keck, M. E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300493 · Cited by 75
Augmentation strategies in patients with refractory depression
Nemeroff, C. B. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:4<169::aid-da3>3.0.co;2-a · Cited by 75
Popik, P., Kozela, E., & Krawczyk, M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705359 · Cited by 75
Olivier, B., Soudijn, W., & van Wijngaarden, I. (2000) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8391-7_3 · Cited by 75
The vasopressin V1b receptor as a therapeutic target in stress-related disorders
Griebel, G., Simiand, J., Stemmelin, J., Gal, C., & Steinberg, R. (2003) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007033482850 · Cited by 74
Levitan, R. D., Shen, J., Jindal, R., Driver, H. S., Kennedy, S. H., & Shapiro, C. M. (2000) · Europe PMC (PubMed Central) · Cited by 74
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential
Scatena, R., Bottoni, P., Martorana, G. E., & Giardina, B. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.7.835 · Cited by 74
Hennings, E. C. P., Kiss, J., Oliveira, K. D., Tóth, P. T., & Vizi, E. S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731043.x · Cited by 74
Redman, J. R., & Francis, A. J. P. (1998) · Journal of Biological Rhythms · doi:10.1177/074873098128999907 · Cited by 74
Feiger, A. D., Bielski, R. J., Bremner, J. D., Heiser, J. F., Trivedi, M. H., Wilcox, C. S., Roberts, D. L., Kensler, T. T., McQuade, R. D., Kaplita, S., et al. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199901000-00002 · Cited by 74
Kowalski, T. J., & McBriar, M. D. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1113 · Cited by 74
Matzen, L., van Amsterdam, C., Rautenberg, W., Greiner, H. E., Harting, J., Seyfried, C. A., & Böttcher, H. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9811054 · Cited by 74
Lead compounds discovered from libraries: Part 2
Gołȩbiowski, A., Klopfenstein, S. R., & Portlock, D. E. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00059-0 · Cited by 74
Treatment of depression in Parkinson's disease
Sawabini, K. A., & Watts, R. L. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.02.002 · Cited by 74
Millan, M. J., Gobert, A., Roux, S., Porsolt, R. D., Meneses, A., Carli, M., Cara, B. D., Jaffard, R., Rivet, J., Lestage, P. J., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069625 · Cited by 74
Self-citationElectroconvulsive therapy in the era of modern psychopharmacology
McCall, W. V. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002437 · Cited by 74
Bennett, B. A., Wichems, C. H., Hollingsworth, C. K., Davies, H. M. L., Thornley, C., Sexton, T., & Childers, S. R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24543-8 · Cited by 74
Harmer, C. J., Perrett, D. I., Cowen, P. J., & Goodwin, G. M. (2001) · Psychopharmacology · doi:10.1007/s002130000654 · Cited by 73
Booij, L., van der Does, W. A. J., Haffmans, P. M. J., Spinhoven, P., & McNally, R. J. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.2.148 · Cited by 73
Duloxetine in treatment of anxiety symptoms associated with depression
Dünner, D. L., GOLDSTEIN, D. J., Mallinckrodt, C. H., Lu, Y., & Detke, M. J. (2003) · Depression and Anxiety · doi:10.1002/da.10122 · Cited by 73
Bartoszyk, G. D., Hegenbart, R., & Ziegler, H. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00999-5 · Cited by 73
Murck, H., Held, K., Ziegenbein, M., Kunzel, H. E., Holsboer, F., & Steiger, A. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.02.006 · Cited by 73
Clinical correlates of recurrent major depression in obsessive-compulsive disorder
Hong, J. P., SAMUELS, J. F., Bienvenu, O. J., Cannistraro, P. A., Grados, M. A., Riddle, M. A., Liang, K., Cullen, B., Hoehn‐Saric, R., & Nestadt, G. (2004) · Depression and Anxiety · doi:10.1002/da.20024 · Cited by 73
Association Between Pain and Depression Among Older Adults in Europe
Onder, G., Landi, F., Gambassi, G., Liperoti, R., Soldato, M., Catananti, C., Finne‐Soveri, H., Katona, C., Carpenter, I., & Bernabei, R. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0804 · Cited by 73
A survey of prescribing practices in the treatment of depression
Petersen, T., Dording, C. M., Neault, N. B., Kornbluh, R., Alpert, J. E., Nierenberg, A. A., Rosenbaum, J. F., & D, M. F. M. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00250-0 · Cited by 73
Jin, N. Y., Kovács, A., Sui, Z., Dewhurst, S., & Maggirwar, S. B. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.010 · Cited by 73
Fuchs, E., h, B. C., & gge, G. F. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200409000-00003 · Cited by 73
Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression
Inoue, T., Tsuchiya, K., Miura, J., Sakakibara, S., Denda, K., Kasahara, T., & Koyama, T. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00666-4 · Cited by 73
Chastrette, N., Cespuglio, R., & Jouvet, M. (1990) · Neuropeptides · doi:10.1016/0143-4179(90)90042-w · Cited by 73
Ninan, P. T., Hassman, H. A., Glass, S., & McManus, F. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0318 · Cited by 72
Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression
Montgomery, S., Entsuah, R., Hackett, D., Kunz, N. R., Rudolph, R. L., & Venlafaxine 335 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0307 · Cited by 72
Maubach, K. A., Martin, K., Chicchi, G. G., Harrison, T., Wheeldon, A., Swain, C. J., Cumberbatch, M. J., Rupniak, N. M. J., & Seabrook, G. R. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00467-5 · Cited by 72
Gobert, A., & Millan, M. J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00035-4 · Cited by 72
Self-citationMidbrain lesions, dopamine and male sexual behavior
Brackett, N. L., Iuvone, P. M., & Edwards, D. A. (1986) · Behavioural Brain Research · doi:10.1016/0166-4328(86)90006-9 · Cited by 72
Bernaerts, P., & Tirelli, E. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00371-6 · Cited by 72
Role of brain α1B‐adrenoceptors in modafinil‐induced behavioral activity
Stone, E. A., Cotecchia, S., Lin, Y., & Quartermain, D. (2002) · Synapse · doi:10.1002/syn.10127 · Cited by 72
5HT Antagonists Attenuate MK801-Impaired Radial Arm Maze Performance in Rats
Boast, C. A., Bartolomeo, A. C., Morris, H., & Moyer, J. A. (1999) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1998.3886 · Cited by 72
Lee, M., Kennett, G. A., Dourish, C. T., & Clifton, P. G. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1162-7 · Cited by 72
Is depression related to subsequent diabetes mellitus?
van den Akker, M., Schuurman, A. G., Metsemakers, J. F. M., & Buntinx, F. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00333.x · Cited by 72
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.